From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis
- PMID: 35763804
- PMCID: PMC9716893
- DOI: 10.1164/rccm.202205-0914ED
From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis
Comment on
-
Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis.Am J Respir Crit Care Med. 2022 Sep 1;206(5):596-607. doi: 10.1164/rccm.202106-1503OC. Am J Respir Crit Care Med. 2022. PMID: 35728047 Free PMC article.
References
-
- Comporti M, Signorini C, Arezzini B, Vecchio D, Monaco B, Gardi C. F2-isoprostanes are not just markers of oxidative stress. Free Radic Biol Med . 2008;44:247–256. - PubMed
-
- Malli F, Bardaka F, Tsilioni I, Karetsi E, Gourgoulianis KI, Daniil Z. 8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis. Food Chem Toxicol . 2013;61:160–163. - PubMed
-
- Chow S, Thomas PS, Malouf M, Yates DH. Exhaled breath condensate (EBC) biomarkers in pulmonary fibrosis. J Breath Res . 2012;6:016004. - PubMed
-
- Arezzini B, Vecchio D, Signorini C, Stringa B, Gardi C. F2-isoprostanes can mediate bleomycin-induced lung fibrosis. Free Radic Biol Med . 2018;115:1–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
